Daniel Zlotoff is a Cardiology physician affiliated with Massachusetts General Hospital. OpenAlex indexes 107 publications with 4,083 citations (h-index 29).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
55 Fruit St
Grb8-813
Boston, MA 021142621
Telephone
203-232-5694Provider last certified this registry record 23 Mar 2020.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20223 payments$42,800openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year20221 payment
- E.R. Squibb & Sons, L.L.C.Program year20212 payments$53,600openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
75.7%Statin16.3%Atorvastatin Calcium81%Rosuvastatin Calcium10%Pravastatin Sodium9%Part D<11 patientsBeta blocker14.8%Metoprolol Succinate81%Carvedilol20%Part D<11 patients+ 8 more classes in this area
Metabolism & gastrointestinal
16.7%SGLT2 inhibitor16.7%Jardiance58%Farxiga42%Part D≥25 patientsBlood & clotting
7.6%Factor Xa inhibitor7.6%Eliquis100%Part D≥17 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Predictors of Long‐Term Survival in Patients With Immune Checkpoint Inhibitor–Associated Myocarditis
Journal of the American Heart Association
2025 - Immune Checkpoint Inhibitors, Atherosclerotic Cardiovascular Events, and Plaque Progression Among Women With Cancer
Journal of the American Heart Association
2025 - Early Renal Outcomes Following Heart Transplantation Using Organs Procured After Circulatory Death
Journal of the American Heart Association
2024
Similar KOLs
Other experts from the same institution or the same specialty.
James Januzzi, MD
Massachusetts General Hospital
Maurizio Fava, MD
Massachusetts General Hospital
Steven Greenberg, MD
Massachusetts General Hospital
David Scadden, MD
Massachusetts General Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”